Rationale, design, and baseline characteristics of 2 large, simple, randomized trials evaluating telmisartan, rampril, and their combination in high-risk patients : The ongoing telmisartan alone and in combination with ramipril global endpoint trial/telmisartan randomized assessment study in ACE intolerant subjects with cardiovascular disease (ONTARGET/TRANSCEND) trials (2004)
- Autor:
- Autor USP: MARIN NETO, JOSE ANTONIO - FMRP
- Unidade: FMRP
- Subjects: DOENÇAS CARDIOVASCULARES; ANGIOTENSINAS
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: American Heart Journal
- ISSN: 0002-8970
- Volume/Número/Paginação/Ano: v. 148, n. 1, p. 52-61, 2004
-
ABNT
MARIN NETO, José Antônio. Rationale, design, and baseline characteristics of 2 large, simple, randomized trials evaluating telmisartan, rampril, and their combination in high-risk patients : The ongoing telmisartan alone and in combination with ramipril global endpoint trial/telmisartan randomized assessment study in ACE intolerant subjects with cardiovascular disease (ONTARGET/TRANSCEND) trials. American Heart Journal, v. 148, n. 1, p. 52-61, 2004Tradução . . Acesso em: 21 jul. 2024. -
APA
Marin Neto, J. A. (2004). Rationale, design, and baseline characteristics of 2 large, simple, randomized trials evaluating telmisartan, rampril, and their combination in high-risk patients : The ongoing telmisartan alone and in combination with ramipril global endpoint trial/telmisartan randomized assessment study in ACE intolerant subjects with cardiovascular disease (ONTARGET/TRANSCEND) trials. American Heart Journal, 148( 1), 52-61. -
NLM
Marin Neto JA. Rationale, design, and baseline characteristics of 2 large, simple, randomized trials evaluating telmisartan, rampril, and their combination in high-risk patients : The ongoing telmisartan alone and in combination with ramipril global endpoint trial/telmisartan randomized assessment study in ACE intolerant subjects with cardiovascular disease (ONTARGET/TRANSCEND) trials. American Heart Journal. 2004 ; 148( 1): 52-61.[citado 2024 jul. 21 ] -
Vancouver
Marin Neto JA. Rationale, design, and baseline characteristics of 2 large, simple, randomized trials evaluating telmisartan, rampril, and their combination in high-risk patients : The ongoing telmisartan alone and in combination with ramipril global endpoint trial/telmisartan randomized assessment study in ACE intolerant subjects with cardiovascular disease (ONTARGET/TRANSCEND) trials. American Heart Journal. 2004 ; 148( 1): 52-61.[citado 2024 jul. 21 ] - Determinacao da lesao miocardica isquemica por 99m-tecnecio-pirofosfato e azul de evans: efeito da dexametasona
- Clinical significance of reduced regional glucose uptake with normal blood flow in patients with chronic coronary artery disease
- Deteccao de viabilidade miocardica: meta atual da avaliacao em cardiopatas isquemicos com disfuncao ventricular
- Significado clinico da redistribuicao reversa de talio-201 na cardiopatia isquemica cronica
- Myocardial viability: comparison of thallium reinjection rest-stress sestamibi and positron emission tomography
- Métodos de avaliação da circulação pulmonar
- Infarto "Necrosette" versus infarto do miocárdio sem supra-desnivelamento ST (IAMSS) tradicionamente definido e evolução hospitalar: resultados do GRACE(Global Registry of Acute Myocardial Events)
- Segurança da combinação de heparina de baixo peso molecular com inibidores da glicoproteína IIB/IIIA: resultados do registro GRACE
- Agradeço pela ocasião de, como editor convidado ...[Editorial]
- Prevalence of autonomic dysfunction and echocardiographic abnormalities in different eletrocardiographic stages of asymptomatic T. cruzi infection: the CHICAMOCHA pilot study
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
